Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Promisemed Hangzhou Meditech CoBJSE:920069 18 PB Ratio is 2.22 as of Sep. 05, 2026, which is 7% below its 10-year median of 2.39. GuruFocus rates BJSE:920069 with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 785 Medical Devices & Instruments companies, Promisemed Hangzhou Meditech Co ranks worse than 52.1% on this metric.
Promisemed Hangzhou Meditech Co Ltd stock PB Ratio (=2.22) is close to 1-year low of 2.12.
The historical rank and industry rank for Promisemed Hangzhou Meditech Co's PB Ratio or its related term are showing as below:
BJSE:920069'
s PB Ratio Range Over the Past 10 Years
Min: 2.12 Med: 2.39 Max: 3.06
Current: 2.22
During the past 4 years, Promisemed Hangzhou Meditech Co's highest PB Ratio was 3.06. The lowest was 2.12. And the median was 2.39.
BJSE:920069's PB Ratio is ranked worse than 52.1% of 785
companies
in the Medical Devices & Instruments industry
Industry Median: 2.15
vs BJSE:920069: 2.22
During the past 12 months, Promisemed Hangzhou Meditech Co's average Book Value Per Share Growth Rate was 14.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 15.20% per year.
During the past 4 years, the highest 3-Year average Book Value Per Share Growth Rate of Promisemed Hangzhou Meditech Co was 15.20% per year. The lowest was 15.20% per year. And the median was 15.20% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Promisemed Hangzhou Meditech Co PB Ratio Related Terms
Promisemed Hangzhou Meditech Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BJSE:920069 vs ISRG, BDX, RMD: PB Ratio Comparison
For the Medical Instruments & Supplies subindustry, Promisemed Hangzhou Meditech Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Promisemed Hangzhou Meditech Co PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Promisemed Hangzhou Meditech Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Promisemed Hangzhou Meditech Co's PB Ratio falls into.
Promisemed Hangzhou Meditech Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Promisemed Hangzhou Meditech Co (BJSE:920069) has a PB Ratio of 2.22 as of Sep. 05, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Promisemed Hangzhou Meditech Co and its competitors. This is near median its historical median of 2.39. Over the past decade, Promisemed Hangzhou Meditech Co's PB Ratio has ranged from 2.12 to 3.06. According to the industry distribution chart, Promisemed Hangzhou Meditech Co ranks #409 out of 785 companies in the Medical Devices & Instruments industry, placing it in the top 52.1%.
Is Promisemed Hangzhou Meditech Co's PB Ratio too high?
Promisemed Hangzhou Meditech Co's current PB Ratio of 2.22 is near median its 10-year median of 2.39. Over the past 10 years, this metric has ranged from a low of 2.12 to a high of 3.06. The Medical Devices & Instruments industry median PB Ratio is 2.15. Promisemed Hangzhou Meditech Co's value of 2.22 is 3.3% above this industry median. Based on the distribution chart, Promisemed Hangzhou Meditech Co ranks #409 out of 785 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Promisemed Hangzhou Meditech Co has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Promisemed Hangzhou Meditech Co's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Promisemed Hangzhou Meditech Co ranks #409 out of 785 companies for PB Ratio. This places Promisemed Hangzhou Meditech Co in the lower half of its industry. The industry median PB Ratio is 2.15. Promisemed Hangzhou Meditech Co's value of 2.22 is 3.3% above this benchmark. Historically, Promisemed Hangzhou Meditech Co's own PB Ratio has ranged from 2.12 to 3.06 over the past decade. While the company's 10-year median is 2.39 vs. the industry median of 2.15, Promisemed Hangzhou Meditech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.15, based on 785 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Promisemed Hangzhou Meditech Co's current PB Ratio of 2.22 is 3.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Promisemed Hangzhou Meditech Co and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Promisemed Hangzhou Meditech Co's current PB Ratio is 2.22, which is near median its own 10-year median of 2.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promisemed Hangzhou Meditech Co stock overvalued right now?
Promisemed Hangzhou Meditech Co (BJSE:920069) has a current PB Ratio of 2.22. The current PB Ratio is 2.22, which is near median its 10-year median of 2.39 and 3.3% above the Medical Devices & Instruments industry median of 2.15. Promisemed Hangzhou Meditech Co's overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Promisemed Hangzhou Meditech Co (BJSE:920069), the current PB Ratio is 2.22 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Promisemed Hangzhou Meditech Co Ltd is engaged in the Research, development, production and sales of diabetes care, universal drug delivery and infusion, and minimally invasive interventional medical devices.
18GF Score
Get the complete analysis for BJSE:920069
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920069 has been successfully added to your 
